Effect of clofibric acid on desmin and vimentin contents in rat myocardiocytes

International Journal of Toxicology

Volumn 25, Issue 5, 2006, Pages 403-408

  Sampayo Reyes, Adriana ^a,d   Narro Juárez, Antonio ^a   Saíd Fernández, Salvador ^a   Lozano Garza, Héctor G ^a   Vargas Villarreal, Javier ^a   Mata Cárdenas, Benito D ^a   Morales Aguilera, Antonio ^b   González Garza, María Teresa ^b   Cortés Gutiérrez, Elva I ^a   Cerda Flores, Ricardo M ^a   Martínez Rodríguez, Herminia G ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b ESCUELA DE MEDICINA Y CIENCIAS DE LA SALUD   (Mexico)

^c Medicina UANL   (Mexico)

^d Instituto Mexicano del Seguro Social ^*  (Mexico)

Author keywords

Clofibrate; Clofibric Acid; Desmin; Myocardiocytes; Vimentin

Indexed keywords

CLOFIBRIC ACID; DESMIN; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DENSITOMETRY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN MODIFICATION; WESTERN BLOTTING;

EID: 33748642173     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810600846989     Document Type: Article

References (22)

1. Balogh, J., M. Merisckay, Z. Li, D. Paulin, and A. Arner. 2002. Hearts from mice lacking desmin have a myopathy with impaired active force generation and unaltered wall compliance. Cardiovasc. Res. 53:439-450.
2. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
3. Burnette, W. N. 1981. "Western blotting": Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112:195-203.
4. Capetanaki, Y. 2002. Desmin cytoskeleton: A potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc. Med. 12:339-348.
5. D'Amati, G., H.J. Kahn, J. Butany, and M.D. Silver. 1992. Altered distribution of desmin filaments in hypertrophic cardiomyopathy: An immunohistochemical study. Mod. Pathol. 5:165-168.
6. Eghdamian, B., and K. Ghose. 1998. Mode of action and adverse effects of lipid lowering drugs. Drugs Today (Barc). 34:943-956.
7. Gonzalez, F. J., A. E. Aranega, A. Linares, J. E. Fernandez, M. A. Muros, C. Velez, L. Alvarez, and A. Aranega. 1991. Influence of fibric acid derivatives on intermediate filament proteins in myocardiocyte cultures. Life Sci. 48:1091-1099.
8. Goudeau, B., A. Dagvadorj, F. Rodrigues-Lima, P. Nedellec, M. Casteras-Simon, E. Perret, S. Langlois, L. Goldfarb, and P. Vicart. 2001. Structural and functional analysis of a new desmin variant causing desmin-related myopathy. Hum. Mutat. 18:388-396.
9. Gould, A. L., J. E. Rossouw, N. C. Santanello, J. F. Heyse, and C. D. Furberg. 1995. Cholesterol reduction yields clinical benefit. A new look at old data. Circulation 91:2274-2282.
10. International Agency for Research on Cancer (IARC). 1972. Clofibrate. In IARC monographs on the evaluation of the carcinogenic risk of chemicals to man. Geneva: World Health Organization.
11. Karp, G. 1987. Biología Celular. México: McGraw Hill-Interamericana.
12. Krakoff, J., B. S. Vela, and E. A. Brinton. 2000. The role of fibric acid derivatives in the secondary prevention of coronary heart disease. Curr. Cardiol. Rep. 2:452-458.
13. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
14. Lewis, W., N. L. Perillo, and B. Gonzalez. 1988. Alpha-actin synthesis changes in cultured cardiac myocytes: relationship to anthracycline structure. J. Lab. Clin. Med. 112:43-51.
15. Luc, G. 2003. Antilipemics: Results of large studies. Therapie 58:23-29.
16. Morales-Aguilera, A., and A. Sampayo-Reyes. 1993. Molecular changes in erythrocyte membranes induced by long-term administration of clofibrate. Eur. J. Pharmacol. 245:89-95.
17. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55-63.
18. Nag, A.C., and S. K. Huffaker. 1998. Distribution and organization of desmin in cultured adult cardiac muscle cells: reflection on function. J. Muscle Res. Cell. Motil. 19:887-895.
19. Newman, T.B., and S.B. Hulley. 1996. Carcinogenicity of lipid-lowering drugs. JAMA 275:55-60.
20. Sampayo-Reyes, A., C.H. Leal Garza, E.I. Cortes-Gutierrez, and A. Morales-Aguilera. 1997. Clofibrate-induced changes in rat erythrocytes are dependent on duration of treatment. Pharmacol. Sci. 3:407-410.
21. Schroder-Bernhardi, D., and G. Dietlein. 2002. Lipid-lowering therapy: Do hospitals influence the prescribing behavior of general practitioners? Int. J. Clin. Pharmacol. Ther. 40:317-321.
22. Thorp, J.M., and W.S. Waring. 1962. Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate. Nature 194:948-949.